




Searching News Database: BioMimetic Therapeutics
HSMN NewsFeed - 15 Nov 2013
Wright Medical Group, Inc. Completes Acquisition of Biotech International
Wright Medical Group, Inc. Completes Acquisition of Biotech International
HSMN NewsFeed - 16 Oct 2013
Wright Medical Group, Inc. Announces Definitive Agreement to Acquire Biotech International
Wright Medical Group, Inc. Announces Definitive Agreement to Acquire Biotech International
HSMN NewsFeed - 1 Mar 2013
Wright Medical Group, Inc. Completes Acquisition of BioMimetic Therapeutics, Inc.
Wright Medical Group, Inc. Completes Acquisition of BioMimetic Therapeutics, Inc.
HSMN NewsFeed - 19 Nov 2012
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
HSMN NewsFeed - 31 Jan 2011
BioMimetic Therapeutics Announces Date of FDA Advisory Panel Review of Augment(TM) Bone Graft
BioMimetic Therapeutics Announces Date of FDA Advisory Panel Review of Augment(TM) Bone Graft
HSMN NewsFeed - 14 Jul 2010
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
HSMN NewsFeed - 28 Mar 2008
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
BioMimetic Therapeutics Addresses FDA Communication on Regranex Safety Review
HSMN NewsFeed - 13 Aug 2007
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
HSMN NewsFeed - 21 Feb 2007
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
HSMN NewsFeed - 25 Jan 2007
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
HSMN NewsFeed - 13 Oct 2006
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity for GEM 21S(R)